Literature DB >> 22988849

Regulation of protein phosphatase 1 by intrinsically disordered proteins.

Meng S Choy1, Rebecca Page, Wolfgang Peti.   

Abstract

PP1 (protein phosphatase 1) is an essential serine/threonine phosphatase that plays a critical role in a broad range of biological processes, from muscle contraction to memory formation. PP1 achieves its biological specificity by forming holoenzymes with more than 200 known regulatory proteins. Interestingly, most of these regulatory proteins (≥ 70%) belong to the class of IDPs (intrinsically disordered proteins). Thus structural studies highlighting the interaction of these IDP regulatory proteins with PP1 are an attractive model system because it allows general parameters for a group of diverse IDPs that interact with the same binding partner to be identified, while also providing fundamental insights into PP1 biology. The present review provides a brief overview of our current understanding of IDP-PP1 interactions, including the importance of pre-formed secondary and tertiary structures for PP1 binding, as well as changes of IDP dynamics upon interacting with PP1.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22988849      PMCID: PMC3502941          DOI: 10.1042/BST20120094

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  46 in total

1.  Calculation of ensembles of structures representing the unfolded state of an SH3 domain.

Authors:  W Y Choy; J D Forman-Kay
Journal:  J Mol Biol       Date:  2001-05-18       Impact factor: 5.469

Review 2.  Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm.

Authors:  P E Wright; H J Dyson
Journal:  J Mol Biol       Date:  1999-10-22       Impact factor: 5.469

3.  A structural model for unfolded proteins from residual dipolar couplings and small-angle x-ray scattering.

Authors:  Pau Bernadó; Laurence Blanchard; Peter Timmins; Dominique Marion; Rob W H Ruigrok; Martin Blackledge
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-11       Impact factor: 11.205

4.  Structure and disorder in an unfolded state under nondenaturing conditions from ensemble models consistent with a large number of experimental restraints.

Authors:  Joseph A Marsh; Julie D Forman-Kay
Journal:  J Mol Biol       Date:  2009-06-06       Impact factor: 5.469

Review 5.  From promiscuity to precision: protein phosphatases get a makeover.

Authors:  David M Virshup; Shirish Shenolikar
Journal:  Mol Cell       Date:  2009-03-13       Impact factor: 17.970

6.  DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. II. Purification and characterization of the phosphoprotein from bovine caudate nucleus.

Authors:  H C Hemmings; A C Nairn; D W Aswad; P Greengard
Journal:  J Neurosci       Date:  1984-01       Impact factor: 6.167

7.  Characterization of the inhibition of protein phosphatase-1 by DARPP-32 and inhibitor-2.

Authors:  H B Huang; A Horiuchi; T Watanabe; S R Shih; H J Tsay; H C Li; P Greengard; A C Nairn
Journal:  J Biol Chem       Date:  1999-03-19       Impact factor: 5.157

8.  Structural diversity in free and bound states of intrinsically disordered protein phosphatase 1 regulators.

Authors:  Joseph A Marsh; Barbara Dancheck; Michael J Ragusa; Marc Allaire; Julie D Forman-Kay; Wolfgang Peti
Journal:  Structure       Date:  2010-09-08       Impact factor: 5.006

9.  Detailed structural characterization of unbound protein phosphatase 1 inhibitors.

Authors:  Barbara Dancheck; Angus C Nairn; Wolfgang Peti
Journal:  Biochemistry       Date:  2008-11-25       Impact factor: 3.162

Review 10.  Biophysical characterization of intrinsically disordered proteins.

Authors:  David Eliezer
Journal:  Curr Opin Struct Biol       Date:  2009-01-21       Impact factor: 6.809

View more
  20 in total

1.  Successful overexpression of wild-type inhibitor-2 of PP1 in cardiovascular cells.

Authors:  Thorsten Krause; Stefanie Grote-Wessels; Felix Balzer; Peter Boknik; Ulrich Gergs; Uwe Kirchhefer; Igor B Buchwalow; Frank U Müller; Wilhelm Schmitz; Joachim Neumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-05-24       Impact factor: 3.000

2.  Flexible Tethering of ASPP Proteins Facilitates PP-1c Catalysis.

Authors:  Yeyun Zhou; Robyn Millott; Hyeong Jin Kim; Shiyun Peng; Ross A Edwards; Tamara Skene-Arnold; Michal Hammel; Susan P Lees-Miller; John A Tainer; Charles F B Holmes; J N Mark Glover
Journal:  Structure       Date:  2019-08-08       Impact factor: 5.006

3.  SDS22 selectively recognizes and traps metal-deficient inactive PP1.

Authors:  Meng S Choy; Thomas M Moon; Rini Ravindran; Johnny A Bray; Lucy C Robinson; Tara L Archuleta; Wuxian Shi; Wolfgang Peti; Kelly Tatchell; Rebecca Page
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-23       Impact factor: 11.205

4.  Understanding the antagonism of retinoblastoma protein dephosphorylation by PNUTS provides insights into the PP1 regulatory code.

Authors:  Meng S Choy; Martina Hieke; Ganesan Senthil Kumar; Greyson R Lewis; Kristofer R Gonzalez-DeWhitt; Rene P Kessler; Benjamin J Stein; Manuel Hessenberger; Angus C Nairn; Wolfgang Peti; Rebecca Page
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-03       Impact factor: 11.205

Review 5.  Viewing serine/threonine protein phosphatases through the eyes of drug designers.

Authors:  Mengmeng Zhang; S D Yogesha; Joshua E Mayfield; Gordon N Gill; Yan Zhang
Journal:  FEBS J       Date:  2013-09-05       Impact factor: 5.542

6.  Human G109E-inhibitor-1 impairs cardiac function and promotes arrhythmias.

Authors:  Kobra Haghighi; Tracy J Pritchard; Guan-Sheng Liu; Vivek P Singh; Philip Bidwell; Chi Keung Lam; Elizabeth Vafiadaki; Parthib Das; Jianyong Ma; Swati Kunduri; Despina Sanoudou; Stela Florea; Erica Vanderbilt; Hong-Shang Wang; Jack Rubinstein; Roger J Hajjar; Evangelia G Kranias
Journal:  J Mol Cell Cardiol       Date:  2015-10-09       Impact factor: 5.000

7.  Histone Deacetylase Inhibitors Target the Leukemic Microenvironment by Enhancing a Nherf1-Protein Phosphatase 1α-TAZ Signaling Pathway in Osteoblasts.

Authors:  Kimberly N Kremer; Amel Dudakovic; Allan D Hess; B Douglas Smith; Judith E Karp; Scott H Kaufmann; Jennifer J Westendorf; Andre J van Wijnen; Karen E Hedin
Journal:  J Biol Chem       Date:  2015-10-21       Impact factor: 5.157

8.  Carboxyl-terminal receptor domains control the differential dephosphorylation of somatostatin receptors by protein phosphatase 1 isoforms.

Authors:  Andreas Lehmann; Andrea Kliewer; Jan Carlo Märtens; Falko Nagel; Stefan Schulz
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

9.  Protein Phosphatase 1c Associated with the Cardiac Sodium Calcium Exchanger 1 Regulates Its Activity by Dephosphorylating Serine 68-phosphorylated Phospholemman.

Authors:  Tandekile Lubelwana Hafver; Kjetil Hodne; Pimthanya Wanichawan; Jan Magnus Aronsen; Bjørn Dalhus; Per Kristian Lunde; Marianne Lunde; Marita Martinsen; Ulla Helene Enger; William Fuller; Ivar Sjaastad; William Edward Louch; Ole Mathias Sejersted; Cathrine Rein Carlson
Journal:  J Biol Chem       Date:  2015-12-14       Impact factor: 5.157

10.  Identification of a protein phosphatase-1/phospholamban complex that is regulated by cAMP-dependent phosphorylation.

Authors:  Elizabeth Vafiadaki; Demetrios A Arvanitis; Despina Sanoudou; Evangelia G Kranias
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.